Neuren Pharmaceuticals | NEU - Cost Of Sales

Stock Price
11.28
Daily Change
-0.20 -1.74%
Monthly
-13.70%
Yearly
-10.48%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD7.45M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Genetic Signatures AUD 6.26M 3.95M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organon & Co USD 745M 25M Sep/2025
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Starpharma Holdings AUD 417K 459K Dec/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025